ArticleJACC. Case reports2026
Diagnosis and Outcome of a Fulminant Case of Dengue Myocarditis.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDengue is a viral zoonotic disease found in tropical and subtropical countries and transmitted by arthropod vectors, primarily Aedes mosquitoes. Dengue manifestations vary, and reinfection can trigger severe disease, including myocarditis. Nonspecific symptoms and serologic cross-reactivity among flaviviruses make etiological diagnosis difficult. CASE SUMMARY: A 21-year-old otherwise healthy woman presented with fever and cardiogenic shock requiring mechanical circulatory support after returning from Brazil. Dengue virus (DENV) serotype-2 antibodies were found, with evidence of prior DENV serotype-1 infection. The patient was treated supportively and eventually recovered full cardiac function. DISCUSSION: Dengue is one of the fastest growing mosquito-borne illnesses globally and is caused by 1 of 4 virus serotypes. There is no specific treatment for the infection, and flavivirus antibody assays are highly cross-reactive, requiring plaque reduction neutralization assays or other specialized tests to differentiate flavivirus infections. TAKE-HOME MESSAGE: Dengue shock syndrome with myocarditis may require mechanical circulatory support but carries a good prognosis for recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.